Actinogen Medical Financials
ACW Stock | 0.04 0 2.78% |
Actinogen | Select Account or Indicator |
Understanding current and past Actinogen Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Actinogen Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Actinogen Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Actinogen Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Actinogen Medical. Check Actinogen Medical's Beneish M Score to see the likelihood of Actinogen Medical's management manipulating its earnings.
Actinogen Medical Stock Summary
Actinogen Medical competes with FireFly Metals, Aurelia Metals, Aussie Broadband, and Retail Food. Actinogen Medical is entity of Australia. It is traded as Stock on AU exchange.Foreign Associate | USA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | Australia Stock View All |
Exchange | Australian Securities Exchange |
ISIN | AU000000ACW3 |
Business Address | 109 Pitt Street, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | actinogen.com.au |
Phone | 61 2 8964 7401 |
You should never invest in Actinogen Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Actinogen Stock, because this is throwing your money away. Analyzing the key information contained in Actinogen Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Actinogen Medical Key Financial Ratios
Actinogen Medical's financial ratios allow both analysts and investors to convert raw data from Actinogen Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Actinogen Medical over time and compare it to other companies across industries.Revenue | 9.93 M | ||||
Gross Profit | 9.93 M | ||||
EBITDA | (12.92 M) | ||||
Net Income | (13.04 M) | ||||
Cash And Equivalents | 7.18 M |
Actinogen Medical Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 18.4M | 23.3M | 15.2M | 21.3M | 24.5M | 25.7M | |
Other Current Liab | 291.7K | 502.5K | 613.2K | 699.1K | 803.9K | 844.1K | |
Cash | 13.4M | 16.4M | 8.5M | 9.5M | 10.9M | 11.4M | |
Net Receivables | 1.5M | 3.9M | 3.9M | 9.4M | 10.8M | 11.4M | |
Total Liab | 920.3K | 1.6M | 1.8M | 1.6M | 1.9M | 2.0M | |
Common Stock | 60.1M | 76.9M | 78.7M | 100.0M | 115.0M | 120.8M | |
Other Current Assets | 90.0K | 104.6K | 344.5K | 108.8K | 125.2K | 134.7K | |
Net Debt | (13.2M) | (16.2M) | (8.4M) | (9.1M) | (8.2M) | (8.6M) | |
Retained Earnings | (48.4M) | (57.9M) | (68.7M) | (81.7M) | (73.6M) | (69.9M) | |
Accounts Payable | 392.2K | 898.7K | 1.1M | 597.2K | 686.8K | 353.5K | |
Total Current Assets | 15.1M | 20.4M | 12.7M | 18.9M | 21.7M | 22.8M | |
Intangible Assets | 3.0M | 2.7M | 2.4M | 2.1M | 2.4M | 2.7M | |
Net Tangible Assets | 7.5M | 14.4M | 19.0M | 11.0M | 12.6M | 10.9M | |
Short Term Debt | 71.2K | 78.3K | 86.9K | 60.7K | 54.6K | 51.9K | |
Net Invested Capital | 17.5M | 21.7M | 13.4M | 19.7M | 22.7M | 17.3M | |
Cash And Equivalents | 3.6M | 7.1M | 12.1M | 7.2M | 8.3M | 7.8M | |
Net Working Capital | 14.3M | 18.9M | 10.9M | 17.5M | 20.1M | 13.5M | |
Capital Stock | 60.1M | 76.9M | 78.7M | 100.0M | 115.0M | 75.5M |
Actinogen Medical Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Interest Expense | 22.3K | 18.5K | 16.6K | 24.3K | 27.9K | 29.3K | |
Total Revenue | 2.0M | 3.6M | 4.9M | 9.9M | 11.4M | 12.0M | |
Gross Profit | 1.6M | 3.2M | 4.5M | 9.9M | 11.4M | 12.0M | |
Operating Income | (5.9M) | (13.2M) | (15.9M) | (12.8M) | (11.6M) | (11.0M) | |
Ebit | (5.7M) | (13.1M) | (15.6M) | (13.3M) | (12.0M) | (11.4M) | |
Ebitda | (5.3M) | (12.7M) | (15.2M) | (12.9M) | (11.6M) | (11.0M) | |
Cost Of Revenue | 386.7K | 400.7K | 405.6K | 416.8K | 479.4K | 334.9K | |
Income Before Tax | (5.8M) | (13.1M) | (15.6M) | (23.0M) | (20.7M) | (19.6M) | |
Net Income | (3.9M) | (9.5M) | (10.8M) | (13.0M) | (11.7M) | (11.2M) | |
Income Tax Expense | (1.8M) | (3.6M) | (4.9M) | (9.9M) | (8.9M) | (8.5M) | |
Research Development | 2.4M | 8.2M | 8.9M | 15.5M | 17.9M | 18.8M | |
Interest Income | 27.1K | 41.1K | 366.7K | 291.0K | 334.7K | 351.4K | |
Net Interest Income | 4.8K | 22.6K | 350.1K | 266.7K | 306.7K | 322.1K |
Actinogen Medical Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Capital Expenditures | 6.2K | 2.9K | 36.6K | 8.2K | 7.3K | 14.4K | |
End Period Cash Flow | 13.4M | 16.4M | 8.5M | 9.5M | 10.9M | 5.5M | |
Change In Cash | 8.4M | 2.9M | (7.9M) | 990.7K | 891.6K | 936.2K | |
Free Cash Flow | (1.7M) | (9.5M) | (8.7M) | (17.0M) | (15.3M) | (14.5M) | |
Depreciation | 386.7K | 400.7K | 405.6K | 416.8K | 479.4K | 244.7K | |
Other Non Cash Items | 1.8M | 3.8M | 2.3M | 912.1K | 1.0M | 1.1M | |
Net Income | (3.9M) | (9.5M) | (10.8M) | (13.0M) | (11.7M) | (11.2M) | |
Investments | (6.2K) | (2.9K) | (36.6K) | (8.2K) | (9.4K) | (9.9K) | |
Change To Netincome | 194.5K | 289.3K | 1.3M | 1.5M | 1.7M | 1.8M | |
Change To Inventory | (100.4K) | (26.1K) | (717.3K) | (313.5K) | (282.1K) | (296.2K) |
Actinogen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Actinogen Medical's current stock value. Our valuation model uses many indicators to compare Actinogen Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Actinogen Medical competition to find correlations between indicators driving Actinogen Medical's intrinsic value. More Info.Actinogen Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Actinogen Medical's earnings, one of the primary drivers of an investment's value.Actinogen Medical Systematic Risk
Actinogen Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Actinogen Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-one with a total number of output elements of fourty. The Beta measures systematic risk based on how returns on Actinogen Medical correlated with the market. If Beta is less than 0 Actinogen Medical generally moves in the opposite direction as compared to the market. If Actinogen Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Actinogen Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Actinogen Medical is generally in the same direction as the market. If Beta > 1 Actinogen Medical moves generally in the same direction as, but more than the movement of the benchmark.
Actinogen Medical Total Assets Over Time
Actinogen Medical Thematic Clasifications
Actinogen Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
Drugs | View |
Actinogen Medical February 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Actinogen Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Actinogen Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Actinogen Medical based on widely used predictive technical indicators. In general, we focus on analyzing Actinogen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Actinogen Medical's daily price indicators and compare them against related drivers.
Downside Deviation | 5.11 | |||
Information Ratio | 0.1371 | |||
Maximum Drawdown | 25.87 | |||
Value At Risk | (7.14) | |||
Potential Upside | 8.33 |
Additional Tools for Actinogen Stock Analysis
When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.